ArticleJAAD case reports2024

The use of biologic medications for the treatment of cutaneous immune-related adverse events secondary to immune checkpoint inhibitors: A single-institution real-life study.

Jade N Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.